Aldeyra Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2013 to Q2 2024.
  • Aldeyra Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $478K, a 9.4% decline year-over-year.
  • Aldeyra Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $2.03M, a 7.01% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Interest Expense for 2023 was $2.07M, a 22.3% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Interest Expense for 2022 was $1.69M, a 2.76% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Interest Expense for 2021 was $1.74M, a 8.51% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.03M $478K -$49.5K -9.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $2.08M $499K +$7.24K +1.47% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $2.07M $514K +$53.4K +11.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $2.02M $539K +$122K +29.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $1.9M $527K +$117K +28.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $1.78M $491K +$85.3K +21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $1.69M $461K +$47.9K +11.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $1.65M $417K +$3.81K +0.92% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $1.64M $410K -$23.1K -5.33% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.67M $406K -$76.6K -15.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.74M $413K -$76.2K -15.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $1.82M $413K -$76.1K -15.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.89M $433K -$52.6K -10.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $1.95M $483K +$42.8K +9.72% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.9M $489K -$54.9K -10.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $1.96M $489K +$460K +1578% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $1.5M $486K +$457K +1597% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.04M $440K +$438K +22317% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $604K $544K +$481K +756% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $123K $29.2K +$308 +1.07% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $123K $28.6K +$2.29K +8.69% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $121K $1.96K -$26.1K -93% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $147K $63.5K +$31K +95.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $116K $28.8K +$1.27K +4.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $115K $26.4K -$105 -0.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $115K $28K +$1.21K +4.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $113K $32.6K +$6.57K +25.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 $107K $27.6K +$924 +3.47% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $106K $26.5K -$1.35K -4.87% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $107K $26.8K +$1.8K +7.2% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $106K $26K -$1.99K -7.1% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-30
Q3 2016 $107K $26.7K -$1.43K -5.08% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $109K $27.8K -$393 -1.39% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $109K $25K -$2.99K -10.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $112K $28K -$5.65K -16.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 $118K $28.1K -$13K -31.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $131K $28.2K -$28K -49.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $159K $28K -$85.2K -75.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $244K $33.6K -$80.5K -70.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $325K $41.1K +$26.6K +184% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $298K $56.2K +$40.9K +268% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $257K $113K +$97.8K +635% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $159K $114K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 $14.5K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $15.3K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $15.4K Jan 1, 2013 Mar 31, 2013 10-Q 2014-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.